Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, Ethiopia

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Legesse, Mengistu ^a,b   Ameni, Gobena ^a   Mamo, Gezahegne ^a,b   Medhin, Girmay ^a   Bjune, Gunnar ^b   Abebe, Fekadu ^b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ETHIOPIA; FECES ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; TUBERCULIN TEST; URINALYSIS; ADOLESCENT; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; ISOLATION AND PURIFICATION; LATENT TUBERCULOSIS; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RECEIVER OPERATING CHARACTERISTIC; SPUTUM; STANDARD; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; HIV SEROPOSITIVITY; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULIN TEST; YOUNG ADULT;

EID: 78650166303     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-354     Document Type: Article

References (43)

1. World Health Organization Global tuberculosis control: surveillance, planning, financing, Geneva, Switzerland 2008, WHO, World Health Organization.
2. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int J Tuberc Lung Dis 1990, 65:6-24.
3. World Health Organization Global Tuberculosis Control, Epidemiology, Strategy, Geneva, Switzerland 2009, WHO, World Health Organization.
4. World Health Organization The Global Plan to Stop TB, 2006-2015. Actions for life - towards a world free of tuberculosis, Geneva 2006, WHO, World Health Organization.
5. Lee E, Holzman RS. Evolution and Current Use of the Tuberculin Test. Clin Infect Dis 2002, 34:365-70. 10.1086/338149, 11774084.
6. Madariaga MG, Jalali Z, Swindells S. Clinical Utility of Interferon Gamma Assay in the Diagnosis of Tuberculosis. J Am Board Fam Med 2007, 20:540-547. 10.3122/jabfm.2007.06.070109, 17954861.
7. Moreno S, Blazquez R, Novoa A, Carpena I, Menasalvas A, Ramirez C, Guerrero C. The Effect of BCG Vaccination on Tuberculin Reactivity and the Booster Effect Among Hospital Employees. Arch Intern Med 2001, 161:1760-1765. 10.1001/archinte.161.14.1760, 11485509.
8. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Veron A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recommended Rep 2005, 54:49-55.
9. Kabeer BSA, Raman B, Thomas A, Perumal V, Raja A. Role of QuantiFERON-TB Gold, Interferon Gamma Inducible Protein-10 and Tuberculin Skin Test in Active Tuberculosis Diagnosis. PLoS ONE 2010, 5:9051-7.
10. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004, 170:59-64. 10.1164/rccm.200402-179OC, 15059788.
11. Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS. Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006, 28:24-30. 10.1183/09031936.06.00016906, 16611658.
12. Pia M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infections; an update. Ann Intern Med 2008, 149:177-184. 2951987, 18593687.
13. Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative Performance of Tuberculin Skin Test, QuantiFERON-TB-Gold In Tube Assay, and T-Spot. TB Test in Contact Investigations for Tuberculosis. Chest 2009, 135:1010-1018. 10.1378/chest.08-2048, 19017873.
14. Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, El-Sadr W. Sensitivity Analysis and Potential Uses of a Novel Gamma Interferon Release Assay for Diagnosis of Tuberculosis. J Clin Microbiol 2006, 44:2844-50. 10.1128/JCM.02411-05, 1594653, 16891501.
15. Park SY, Park YB, Choi JH, Lee JY, Kim JS, Mo EK. The Diagnostic Value of Interferon-γ Assay in Patients with Active Tuberculosis. Tuberc Respir Dis 2009, 66:13-19.
16. Toshiyama T, Harada N, Higuchi K, Sekiya Y, Uchimura K. Use of the QuantiFERON-TB Gold Test for screening tuberculosis contacts and predicting active disease. Int J Tuberc Lung Dis 2010, 14:819-827.
17. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 2006, 6:413-22. 10.1586/14737159.6.3.413, 16706743.
18. Menzies D, Pia M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007, 146:340-354.
19. Lalvani A, Nagvenkar P, Udwadia Z, Pathan AA, Wilkinson KA, Shastri JS, Ewer K, Hill AVS, Mehta A, Rodrigues C. Enumeration of T cells Specific for RD1-Encoded Antigens Suggests a High Prevalence of Latent Mycobacterium tuberculosis Infection in Healthy Urban Indians. J Infect Dis 2000, 183:469-77. 10.1086/318081, 11133379.
20. Chee CBE, Gan SH, KhinMar KW, Barkham TM, Koh CK, Liang S, Wang YT. Comparison of Sensitivity of Two Commercial Gamma Interferon Release Assay for Pulmonary Tuberculosis. J Clin Microbiol 2008, 46:1935-1940. 10.1128/JCM.02403-07, 2446854, 18400912.
21. Harada N, Higuchi K, Sekiya Y, Rothel J, Kitoh T, Mori T. Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10. Kekkaku 2004, 79:725-35.
22. Soysal A, Torun T, Efe S, Gencer H, Tahaoglu K, Bakir M. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Int J Tuberc Lung Dis 2008, 12:50-56.
23. The Afar People of the Horn of Africa. , http://www.orvillejenkins.com/profiles/afar.html
24. Medicin Sans Frontieres Treating Ethiopian Nomads Living with Tuberculosis. 2005, MSF, Medicin Sans Frontieres., http://doctorswithoutborders.org/news/article.cfm?id=1581
25. International Union Against Tuberculosis and Lung Disease Technical guide. Sputum Examination for Tuberculosis by Direct Microscopy in Low-Income Countries. 2000, Paris, France: IUATLD, International Union Against Tuberculosis and Lung Disease.
26. Dhingra VK, Aggarwal N, Rajpal S, Aggarwal JK, Gaur SN. Validity and Reliability of Sputum Smear Examination as Diagnostic and Screening Test for Tuberculosis. Indian J Allergy Asthma Immunol 2003, 17:67-69.
27. Selvakumar N, Rahman F, Garg R, Rajasekaran S, Mohan NS, Thyagarajan K, Sundaram V, Santha T, Frieden TR, Narayanan PR. Evaluation of the Phenol Ammonium Sulfate Sedimentation Smear Microscopy Method for Diagnosis of Pulmonary Tuberculosis. J Clin Microbiol 2002, 40:3017-3020. 10.1128/JCM.40.8.3017-3020.2002, 120642, 12149368.
28. Ayele B, Erko B, Legesse M, Hailu A, Medhin G. Evaluation of circulating cathodic antigen (CCA) strip for diagnosis of urinary schistosomiasis in Hassoba school children, Afar, Ethiopia. Parasite 2008, 15:69-75.
29. Michael JS, Daley P, Armstrong L, Kalaiselvan S, Chordia P, Asha LM, Mathai D, John KR, Pai M. Comparison of QuantiFERON-TB Gold In-Tube to Tuberculin skin test for the diagnosis of Active tuberculosis in India-preliminary analysis. Int J Infect Dis 2008, 12:323-324.
30. Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, Hill AVS, Lalvani A. Direct Ex Vivo Analysis of Antigen-specific IFN-γ-Secreting CD4 T cells in Mycobacterium tuberculosis-infected Individuals: Associations with Clinical Disease state and Effect of Treatment. J Immunol 2001, 167:5217-25.
31. Raby E, Moyo M, Devendra A, Banda J, De Haas P, Ayles H, Godfrey-Faussett P. The Effects of HIV on the Sensitivity of a Whole Blood IFN-γ Release Assay in Zambian Adults with Active Tuberculosis. PLoS ONE 2008, 3:2489-2495.
32. Kanunfre KA, Leite OHM, Lopes MI, Litvoc M, Ferreira AW. Enhancement of Diagnostic Efficiency by a Gamma Interferon Release Assay for Pulmonary Tuberculosis. Clin Vaccine Immunol 2008, 15:028-1030.
33. Dheda K, Smit RZ, Badri M, Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high burden vs. low-burden settings. Curr Opin Pulm Med 2009, 15:188-200. 10.1097/MCP.0b013e32832a0adc, 19387262.
34. Shanaube K, Haas PD, Schaap A, Moyo M, Kosloff B, Devendra A, Raby E, Godfrey-Faussett P, Ayles H. Intra-assay Reliability and Robustness of QuantiFERON-TB Gold In-Tube Test in Zambia. Int J Tuberc Lung Dis 2010, 14:828-833.
35. Chee CBE, Barkham TM, KhinMar KW, Gan SH, Wang YT. Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis. Eur J Clin Microbiol Infect Dis 2009, 28:667-670. 10.1007/s10096-008-0670-8, 19020909.
36. Thompson NJ, Glassroth JL, Snider DE, Farer LS. The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis 1979, 119:587-97.
37. Pelly TF, Santillan CF, Gilman RH, Cabrera LZ, Garcia E, Vidal C, Zimic MJ, Moore DAJ, Evans CA. Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis 9:977-84. 2912519, 16161252.
38. Casas I, Latorre I, Esteve M, Ruiz-Manzano J, Rodriguez D, Prat C, Garcia-Olive I, Lacoma A, Ausina V, Dominguez J. Evaluation of Interferon-Gamma Release Assays in the Diagnosis of Recent Tuberculosis Infections in Health Care Workers. PLoS one 2009, 4:e6686. 10.1371/journal.pone.0006686, 2726945, 19701460.
39. Winqvist N, Bjorkman P, Noren A, Miorner H. Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area. BMC Infect Dis 2009, 9:105-112. 10.1186/1471-2334-9-105, 2713243, 19575781.
40. Ravn P, Munk ME, Andersen AB, Lundgren B, Lundgren JD, Nielsen LN, Kok-Jensen A, Andersen P, Weldingh K. Prospective Evaluation of a whole-blood Test Using Mycobacterium tuberculosis-specific Antigens ESAT-6 and CFP-10 for the Diagnosis of Active Tuberculosis. Clin Diagnost Lab Immunol 2005, 12:91-96.
41. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen L, Ravn P. Latent Tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test. Respir Research 2006, 7:56-64.
42. Demissie A, Ravn P, Olobo J, Doherty TM, Eguale T, Geletu M, Hailu W, Andersen P, Britton S. T-Cell Recognition of Mycobacterium tuberculosis Culture Filtrate Fractions in Tuberculosis Patients and Their Household Contacts. Infect Immun 1999, 67:5967-71. 96981, 10531255.
43. Demissie A, Wassie L, Abebe M, Aseffa A, Rook G, Zumla A, Andersen P, Doherty TM, . the VACSEL Study Group The 6-Kilodalton Earyl Secreted Antigenic Target-Responsive, Asymptomatic Contacts of Tuberculosis Patients Express Elevated Levels of Interleukin-4 and Reduced levels of Gamma Interferon. Infect Immun 2006, 74:2817-22. 10.1128/IAI.74.5.2817-2822.2006, 1459691, 16622219, the VACSEL Study Group.